Information on HealthGate.com is not a
substitute for professional medical care or
advice but should be used only as an
aid in understanding current medical
knowledge. A physician should always be
consulted for any health problem or medical
condition.
Chiasmal infarction and sudden blindness
caused by mucormycosis in AIDS and
diabetes mellitus.
Author
Lee BL; Holland GN; Glasgow BJ
Address
UCLA Ocular Inflammatory Disease Center,
USA.
Source
Am J Ophthalmol, 1996 Dec, 122:6, 895-6
Abstract
PURPOSE: To report rapidly progressive
rhino-orbitocerebral mucormycosis in a
47-year-old woman with both diabetes
mellitus and the acquired immunodeficiency
syndrome (AIDS). METHOD: Case report
including postmortem examination of the
eyes, orbit, and brain of a patient with
rhino-orbitocerebral mucormycosis,
diabetes mellitus, and AIDS. RESULTS:
Invasion by hyphae of the Rhizopus species
produced an occlusive vasculitis and
massive infarction of the optic chiasm.
Fungal organisms were discovered in
multiple granulomata of the optic nerve.
CONCLUSION: Infarction at the optic chiasm
probably caused sudden blindness in this
patient.
Diabetes, the leading cause of new
blindness among U.S. adults aged 20-74
years, accounts for approximately 8% of
cases of legal blindness and 12% of all
new cases of blindness in the United
States each year. One of the national
health objectives for the year 2000 is to
decrease by 50% the incidence of blindness
caused by diabetes (objective 17.10).
However, surveillance for blindness among
persons with diabetes has not been
conducted nationally, and national
prevalence estimates of blindness caused
by diabetes have been based on state data
from the register of the Massachusetts
Commission for the Blind (MCB). To
characterize recent trends, data on legal
blindness caused by diabetes among adults
with diabetes in Massachusetts were
examined for 1987-1994. This report
summarizes the results of that analysis,
which indicate that in Massachusetts, the
overall incidence and prevalence of legal
blindness caused by diabetes did not
decrease, despite the availability of
methods to prevent vision loss.
New blindness in diabetes reduced by
more than one-third in Stockholm County.
Author
Bäcklund LB; Algvere PV; Rosenqvist U
Address
Department of Ophthalmology, Karolinska
Institutet, St Erik's Eye Hospital,
Stockholm, Sweden.
Source
Diabet Med, 1997 Sep, 14:9, 732-40
Abstract
To monitor changes over time in the
incidence of blindness among people with
diabetes, referrals (mentioning diabetes)
to all vision rehabilitation centres in
Stockholm County (1995 population 1 725
756) during 1981-1995 were registered. A
mass mailing to people with diabetes in
1989 urged them to have their eyes
examined. Mobile fundus photography teams
initiated early diagnosis of diabetic
retinopathy in primary health care in
1990. Referrals with diabetes and
blindness, defined (WHO, ICD 10) as
best-corrected visual acuity (VA) of the
better eye less than 3/60 (0.05), occurred
for 172 persons (7.6% of those referred
with diabetes). During 1981-1985, 93 were
referred (95% confidence interval 75 to
114); 1986-1990, 51 (38 to 67); 1991-1995,
28 (19 to 41). Five-year average annual
incidence rate of referrals with blindness
was reduced by 47% from 1.2 to 0.63 to
0.33 per 100,000 population. Mean yearly
reduction during 1981-1995 was 11% (8 to
15%), 11.5% (8 to 15%) if blindness was
defined as in the UK (VA 3/60 or less),
and 7% (4 to 9%) for legal blindness (VA
6/60 or less); test for trend p < 0.001
(Poisson regression analysis). This is the
first report of reduction in a
geographical region of a proxy measure for
new blindness in diabetes by one-third or
more, attaining one of the main targets of
the St Vincent Declaration.
Blindness in patients with diabetes who
have been screened for eye disease.
Author
Rhatigan MC; Leese GP; Ellis J;
Ellingford A; Morris AD; Newton RW;
Roxburgh ST
Address
Department of Ophthalmology, Ninewells
Hospital and Medical School, Dundee, UK.
Source
Eye, 1999 Apr, 13 ( Pt 2):, 166-9
Abstract
PURPOSE: Detection of diabetic
retinopathy by screening is a major public
health concern. Fundus photography has
been shown to be a useful screening tool
for the detection of diabetic retinopathy.
In this paper the authors assess the
incidence of blind and partially sighted
registration due to diabetic eye disease
in patients screened by a mobile fundus
photography unit and identify the factors
that contributed to loss of vision in the
registered group. METHODS: A retrospective
review of blind and partially sighted
registrations between 1990 and 1995 was
performed in a diabetic population
screened by a mobile fundus photography
unit in a region with a population of
390,000. The incidence of blind and
partially sighted registration in the
screened diabetic population was
calculated. In the registered group, cause
of visual loss, accuracy of photograph
reporting, delay in laser treatment,
adequacy of laser treatment and
non-attendance rates at ophthalmic clinics
were assessed. RESULTS: Of the 5390
patients screened by the mobile unit over
6 years, 68 (210 per 10(5) patient-years)
were registered blind or partially
sighted, but in only 17 patients (53 per
10(5) patient-years) was this as a result
of diabetes. The factors contributing to
loss of vision were found to be failure of
laser treatment, rapidly progressive
disease and poor patient attendance.
CONCLUSIONS: As the majority of visual
impairment in patients with diabetes is
not due to diabetic retinopathy, this has
important implications for screening
programmes and may make the St Vincent
Declaration targets difficult to achieve.
The rate of new blind and partially
sighted registration due to diabetes in
the screened population was low at 53 per
10(5) patient-years (95% confidence
interval, 29-76).
An approach to the prevention of
blindness in diabetes.
Author
Herman WH; Teutsch SM; Sepe SJ; Sinnock
P; Klein R
Address
Source
Diabetes Care, 1983 Nov, 6:6, 608-13
Abstract
Diabetic eye disease is the leading
cause of new cases of legal blindness in
American adults under the age of 65 yr.
Diabetic persons are at risk for visual
loss due to diabetic retinopathy,
glaucoma, and cataracts. Better
understanding of the natural histories of
these complications and recent advances in
treatment have provided a rationale for
developing an approach to prevent visual
loss. This approach requires that diabetic
patients who are at high risk for visual
loss, and not under the care of
ophthalmologists, be systematically
screened, referred, and treated.
Transitory blindness during ethanol and
phenethylbiguanide induced lactic acidosis
in a subject with diabetes mellitus. A
case report.
Author
Sorensen PN
Address
Source
Acta Ophthalmol (Copenh), 1977 Apr,
55:2, 177-82
Abstract
Transitory blindness is described in a
diabetic patient with typical ethanol- and
phenethylbiguanide induced lactic
acidosis. The blindness developed in the
course of 8 hours, but the vision returned
during treatment with iv bicarbonate,
insulin and glucose. The condition is
discussed in relation to a presumed
inhibition of the oxidative metabolism in
the retina.
Elimination of preventable blindness
from diabetes by the year 2000.
Author
Plechaty G; Smith RE; Patz A
Address
Source
Hawaii Med J, 1992 Jul, 51:7, 186, 196
Abstract
"Diabetes 2000" will parallel
a major diabetic retinopathy public
information campaign recently announced by
the National Eye Institute. The NEI's
National Eye Health Education Program (NEHEP),
which targets both diabetic retinopathy
and glaucoma, is fashioned along the lines
of earlier federal initiatives against
smoking and high blood pressure. By
continuously updating our medical
knowledge and skills related to this
multisystem disorder, and by forging
partnerships between physicians in the
effective and efficient management of
diabetic patients, we have a unique and
important opportunity--we can reduce
preventable blindness from diabetes by the
year 2000.
Association of blindness to
intensification of glycemic control in
insulin-dependent diabetes mellitus.
Author
Moskalets E; Galstyan G; Starostina E;
Antsiferov M; Chantelau E
Address
Diabetes Care and Education Unit,
National Center for Endocrinology, Moscow,
Russia.
Source
J Diabetes Complications, 1994 Jan, 8:1,
45-50
Abstract
Intensive glycemic control (IGC) in
previously hyperglycemic insulin-dependent
diabetes mellitus (IDDM) patients is
associated with a decreased long-term risk
of progression of diabetic retinopathy
(DR); up to 12 months after institution of
IGC, however, the risk of progression of
DR transiently increases. In an
observational study, a cohort of 122
patients with IDDM was followed
prospectively for changes in glycosylated
hemoglobin (HbA1, normal < 8%) and in
DR 0-12 months after institution of IGC.
In six of these patients (women, mean age
24 years, duration of diabetes 14.3 years,
with incipient nephropathy and
retinopathy) a total of seven eyes went
blind after 6-12 months of IGC, despite
laser coagulation treatment. From the
whole sample, a control groups of eight
patients (six women) was set up, matched
for age, duration of IDDM, degree of
retinopathy, visual acuity, blood
pressure, and microalbuminuria, with
preserved vision after 12 months of IGC.
In the case patients, the mean (95%
confidence interval) initial HbA1 was
14.9% (13.8%-16.1%), versus 13.4%
(12.4%-14.4%) in the control patients (p
< 0.05). The mean HbA1 decrements after
4 months of IGC, were 3.0% (1.9%-4.1%) in
the cases, and 2.1% (1.2%-3.0%) in the
controls (NS); and after 12 months, the
respective decrements were 4.9%
(2.4%-7.4%) in the cases versus 2.0%
(0.5%-3.5%) in the controls (p = 0.04). In
conclusion, IGC with a decrement of >
2% per year is associated with a high risk
of progression of antecedent diabetic
retinopathy to blindness in IDDM patients
with an extremely high initial
HbA1.(ABSTRACT TRUNCATED AT 250 WORDS)
Diabetes insipidus and blindness caused
by a suprasellar tumor: Pieter Pauw's
observations from the 16th century [see
comments]
Author
Kivelä T; Pelkonen R; Oja M; Heiskanen
O
Address
Department of Ophthalmology, Helsinki
University Central Hospital, Finland.
tekivela@cc.helsinki.fi
Source
JAMA, 1998 Jan, 279:1, 48-50
Abstract
Tumors in the suprasellar region may
cause both visual and endocrinologic
symptoms. This association, well known to
modern physicians, was established during
the 19th century. However, we have
identified a 16th-century autopsy report,
written by the Dutch professor of anatomy
Pieter Pauw (1564-1617), which describes
an 18-year-old girl who developed marked
polyuria and subsequently became totally
blind from a cystic tumor compressing the
optic chiasm. Based on prevailing theories
on the nature of diabetes, Pauw attributed
the disease to the kidneys. Undoubtedly,
however, his lucid report is the earliest
known account of diabetes insipidus caused
by an arachnoid cyst, the Rathke cleft
cyst, or craniopharyngioma in the region
of the pouch of Rathke. The description
also gives insights into the role of
anatomic dissections in late 16th-century
northern Europe.
Incidence of blindness in relation to
diabetes. A population-based study.
Author
Trautner C; Icks A; Haastert B; Plum F;
Berger M
Address
Department of Biometrics and
Epidemiology, Diabetes Research Institute,
Heinrich Heine University, DÂusseldorf,
Germany. trau@dfi.uni-duesseldorf.de
Source
Diabetes Care, 1997 Jul, 20:7, 1147-53
Abstract
OBJECTIVE: A reduction of
diabetes-related blindness was declared a
primary objective for Europe (St. Vincent
Declaration). We collected data about
incidence rates of blindness in the
diabetic population compared with the
nondiabetic population. Up to now, such
data are scarce-even worldwide. RESEARCH
DESIGN AND METHODS: A complete list of
newly registered blindness allowance
recipients was drawn up in the district of
Württemberg-Hohenzollern, Germany,
between 1990 and 1993. From these data, we
estimated age-specific and standardized
incidence rates of blindness in the
entire, the diabetic, and the nondiabetic
population, as well as relative and
attributable risks due to diabetes.
RESULTS: There were 2,714 people meeting
the inclusion criteria; 1,823 (67.2%) were
female and 781 (28.8%) had diabetes. In
318 subjects, diabetes was likely to be
the only cause of blindness; in 192
subjects, it was one of several
contributory causes. Age of women was 73.9
+/- 19.4 years (mean +/- SD) and of men
63.3 +/- 25.5 years. Results standardized
to the (West) German population are as
follows: incidence rates (per 100,000
person-years): total population: 13.5;
diabetic population: 60.6; nondiabetic
population: 11.6; relative risk: 5.2;
attributable risk among exposed: 0.81; and
population attributable risk: 0.14. The
relative risks decreased considerably with
increasing age. When the study is repeated
to monitor the St. Vincent targets, a
reduction in the incidence rate of
blindness in the diabetic population by
17% will be detected with 95% power.
CONCLUSIONS: Great relative and
attributable risks, especially in younger
age-groups, indicate the need for
increased attention to preventive measures
for microvascular complications.
Blindness due to diabetes:
population-based age- and sex-specific
incidence rates.
Author
Icks A; Trautner C; Haastert B; Berger
M; Giani G
Address
Department of Biometrics and
Epidemiology, Diabetes Research Institute
at DÂusseldorf University, Germany.
Source
Diabet Med, 1997 Jul, 14:7, 571-5
Abstract
Reducing the incidence of diabetic
retinopathy and blindness was declared one
of the main objectives in St Vincent. To
date, hardly any valid data are available
on the age- and sex-specific incidence of
diabetes-related blindness. They are
necessary, however, to evaluate
intervention activities. Therefore, we
used a population-based registry of
blindness to calculate incidence of
blindness due to diabetes. In one German
district (Rhineland) we obtained complete
lists of cases of blindness newly
registered in 1990 and 1991 and coded as
blind due to diabetes (n = 589). We
estimated age-specific incidence rates in
the entire as well as in the diabetic
population. Incidence rates of blindness
due to diabetes (100,000(-1) * year(-1)),
standardized to the West-German
population, were 3.2 (CI 95%: 2.9;3.4) in
the entire population and 60.5 (CI 95%:
45.7;75.4) in the diabetic population.
Incidence rates in the diabetic population
showed a peak between 20 and 40 years of
age, probably due to complications of Type
1 diabetes. Incidence was higher in
diabetic women than in diabetic men (p
< 0.05 at ages > or =40 years).
Repeating the study will detect a decrease
in the incidence of blindness due to
diabetes by one-third with over 99% power.
Adolescence; Adult; Age Factors; Aged;
Aged, 80 and over; Child; Child,
Preschool; Female; Germany|EP; Human;
Incidence; Infant; Infant, Newborn; Male;
Middle Age; Reference Standards;
Registries|SN/ST; Sex Factors; Support,
Non-U.S. Gov't
Publication Type
JOURNAL ARTICLE
ISSN
0742-3071
Country of Publication
ENGLAND
Information on HealthGate.com
is not a substitute for professional medical
care or advice but should be used only as
an aid in understanding current medical
knowledge. A physician should always be
consulted for any health problem or medical
condition.
SUBSCRIBE:
The Wednesday Letter is a free electronic monthly newsletter written and published by Karl Loren.
You can view more than 50 back issues of this publication by clicking here.
The Wednesday Letter subscription list is maintained on a secure server, no name is ever given or sold to anyone, and it is never used except for this Newsletter.
It is automatically published on the Tuesday night just before the first Wednesday of every month.
You can subscribe to this free monthly electronic letter by entering your eMail address and name below.
You will then automatically receive a request for confirmation, sent to whatever address you have entered.
If you do NOT receive this confirmation request, then you will not be subscribed.
There may have been an error with your address and you should resubmit.
The letter is never sent twice to the same address -- so you do not have to worry about a duplicate subscription.
When you receive this confirmation request you must reply to it, or your subscription will not become active.
No one can subscribe your name, and address, without you being notified, and if you get an unwanted notice of subscription you only need to DO NOTHING and the subscription will NOT be active.
REMOVAL:
You can remove yourself from the subscription list in several different ways.
Click here to read about this entire newsletter system.
Every edition of The Wednesday Letter is delivered to your address with YOUR name and address in view on the letter, with a link that allows you to remove THAT name from the subscription list.
If you try to send this removal message from an address different from the one you used to send in your original confirmation, then you will get a warning notice first, sent to the subscription address, asking you to confirm that you want to be removed from the list -- by replying to THAT request for confirmation, you will then be automatically removed.
Thus, no one else can unsubscribe you, from some other computer, without your knowledge.
But, if you send in the unsubscribe notice from the same machine used to receive the Letter, then the removal from the subscription list is automatic.
Personal Message:
When you send a personal message to Karl Loren, you will receive a personal reply as per his instructions.
Karl pledges that every personal message will get a personal answer. When you provide your mail address, we will send you free information including our free catalog and a cassette tape lecture by Karl Loren about heart disease, no charge, by mail, even if outside the US.
You can select particular information you would like to receive, along with the free cassette tape and catalog.
Click
here to add the Wednesday Letter as a Channel on your desktop.
If your browser is so-equipped, you will be guided through a series of simple
questions (about subscription information). Depending on your choices you
can show the Vibrant Life Wednesday Letter as one of your "active
channels" which will automatically download the new Wednesday Letter every
month. In this way you can have the Wednesday Letter delivered to your
desktop during the night (or your schedule) for immediate viewing in your
browser. You can turn on or off this channel, at will, and delete the
channel from your desktop at any time. With this feature operating you can
click on the Wednesday Letter channel at any time to read the most recent copy
of this electronic letter.
You can reach Vibrant Life in many ways, including by mail to
Vibrant Life, 2808 N. Naomi St., Burbank, CA 91504.
Within the US and Canada, use
the toll free number: (800) 523-4521,
the local number: (818) 558-1799,
the FAX: (818) 558-7299,
eMail to kimberly@oralchelation.com
or any one of the hundreds of message forms throughout the 50 web sites.
Vibrant Life normally ships the same day we get an order.
There are message forms on each of the 100,000+ pages on this and other sites where you can communicate with Vibrant Life.
Check out our companion site, at: http://www.oralchelation.net
where Karl's 2000 page book is published. Karl Loren is the author and
webmaster for this BOOK, as well as
for another web site about ORAL CHELATION.
His personal philosophical articles are at PHILOSOPHY.
Click
here to add the Wednesday Letter as a Channel on your desktop.
If your browser is so-equipped, you will be guided through a series of simple
questions (about subscription information). Depending on your choices you
can show the Vibrant Life Wednesday Letter as one of your "active
channels" which will automatically download the new Wednesday Letter every
month. In this way you can have the Wednesday Letter delivered to your
desktop during the night (or your schedule) for immediate viewing in your
browser. You can turn on or off this channel, at will, and delete the
channel from your desktop at any time. With this feature operating you can
click on the Wednesday Letter channel at any time to read the most recent copy
of this electronic letter.
You can reach Vibrant Life in many ways, including by mail to
Vibrant Life, 2808 N. Naomi St., Burbank, CA 91504.
Within the US and Canada, use
the toll free number: (800) 523-4521,
the local number: (818) 558-1799,
the FAX: (818) 558-7299,
eMail to kimberly@oralchelation.com
or any one of the hundreds of message forms throughout the 50 web sites.
Vibrant Life normally ships the same day we get an order.
There are message forms on each of the 100,000+ pages on this and other sites where you can communicate with Vibrant Life.
Check out our companion site, at: http://www.oralchelation.net
where Karl's 2000 page book is published. Karl Loren is the author and
webmaster for this BOOK, as well as
for another web site about ORAL CHELATION.
His personal philosophical articles are at PHILOSOPHY.
Click
here to add the Wednesday Letter as a Channel on your desktop.
If your browser is so-equipped, you will be guided through a series of simple
questions (about subscription information). Depending on your choices you
can show the Vibrant Life Wednesday Letter as one of your "active
channels" which will automatically download the new Wednesday Letter every
month. In this way you can have the Wednesday Letter delivered to your
desktop during the night (or your schedule) for immediate viewing in your
browser. You can turn on or off this channel, at will, and delete the
channel from your desktop at any time. With this feature operating you can
click on the Wednesday Letter channel at any time to read the most recent copy
of this electronic letter.
You can reach Vibrant Life in many ways, including by mail to
Vibrant Life, 2808 N. Naomi St., Burbank, CA 91504.
Within the US and Canada, use
the toll free number: (800) 523-4521,
the local number: (818) 558-1799,
the FAX: (818) 558-7299,
eMail to kimberly@oralchelation.com
or any one of the hundreds of message forms throughout the 50 web sites.
Vibrant Life normally ships the same day we get an order.
There are message forms on each of the 100,000+ pages on this and other sites where you can communicate with Vibrant Life.
Check out our companion site, at: http://www.oralchelation.net
where Karl's 2000 page book is published. Karl Loren is the author and
webmaster for this BOOK, as well as
for another web site about ORAL CHELATION.
His personal philosophical articles are at PHILOSOPHY.
Click
here to add the Wednesday Letter as a Channel on your desktop.
If your browser is so-equipped, you will be guided through a series of simple
questions (about subscription information). Depending on your choices you
can show the Vibrant Life Wednesday Letter as one of your "active
channels" which will automatically download the new Wednesday Letter every
month. In this way you can have the Wednesday Letter delivered to your
desktop during the night (or your schedule) for immediate viewing in your
browser. You can turn on or off this channel, at will, and delete the
channel from your desktop at any time. With this feature operating you can
click on the Wednesday Letter channel at any time to read the most recent copy
of this electronic letter.
You can reach Vibrant Life in many ways, including by mail to
Vibrant Life, 2808 N. Naomi St., Burbank, CA 91504.
Within the US and Canada, use
the toll free number: (800) 523-4521,
the local number: (818) 558-1799,
the FAX: (818) 558-7299,
eMail to kimberly@oralchelation.com
or any one of the hundreds of message forms throughout the 50 web sites.
Vibrant Life normally ships the same day we get an order.
There are message forms on each of the 100,000+ pages on this and other sites where you can communicate with Vibrant Life.
Check out our companion site, at: http://www.oralchelation.net
where Karl's 2000 page book is published. Karl Loren is the author and
webmaster for this BOOK, as well as
for another web site about ORAL CHELATION.
His personal philosophical articles are at PHILOSOPHY.